Suncoast Equity Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Suncoast Equity Management's LLY Position: Q1 2026 in Review
Suncoast Equity Management reduced its Eli Lilly (LLY) stake by 8.8% in Q1 2026, selling an estimated $3.81M and leaving 38,951 shares worth $35.8M. The position accounts for 4.3% of the portfolio, ranked #9.
Suncoast Equity Management first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $45.9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Suncoast Equity Management held 38,951 shares of Eli Lilly worth $35.8M as of Q1 2026.
- Suncoast Equity Management sold 3,760 Eli Lilly shares in Q1 2026, an estimated $3.81M.
- Eli Lilly made up 4.3% of Suncoast Equity Management's portfolio in Q1 2026, its #9 holding.
- Suncoast Equity Management first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
- Suncoast Equity Management's Eli Lilly position peaked at $45.9M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Suncoast Equity Management's 13F filing for Q1 2026, filed 8 May 2026.